Ozempic does not have a specific BMI requirement. It is FDA-approved to treat type 2 diabetes, not obesity, so the official criteria center on your blood sugar diagnosis rather than your weight. If you have type 2 diabetes, your doctor can prescribe Ozempic regardless of your BMI. The confusion comes from the fact that a related drug, Wegovy, which contains the same active ingredient, does have strict BMI thresholds for weight management.
Why Ozempic Has No BMI Cutoff
The FDA approved Ozempic for two purposes: improving blood sugar control in adults with type 2 diabetes, and reducing the risk of heart attack, stroke, and cardiovascular death in adults with type 2 diabetes and established heart disease. Neither indication mentions body weight or BMI. A person with type 2 diabetes who has a BMI of 24 is technically just as eligible as someone with a BMI of 38, as long as the prescriber determines it’s appropriate for their diabetes management.
That said, many people seek Ozempic specifically for weight loss, and many doctors prescribe it off-label for that purpose. When a doctor writes an off-label prescription for weight management, they typically follow the same BMI guidelines that apply to drugs officially approved for obesity.
The BMI Thresholds That Actually Matter
If you’re looking at semaglutide for weight loss rather than diabetes, the relevant numbers come from Wegovy’s FDA label and from clinical guidelines published by the Endocrine Society. Both use the same two-tier system:
- BMI of 30 or higher: You qualify based on weight alone. This is the clinical definition of obesity.
- BMI of 27 or higher: You qualify if you also have at least one weight-related health condition, such as high blood pressure, high cholesterol, type 2 diabetes, or obstructive sleep apnea.
These thresholds apply broadly across weight loss medications, not just semaglutide. They represent the point at which clinical guidelines say the benefits of pharmacotherapy outweigh the risks. Below a BMI of 27, most prescribers will not write a prescription for any weight loss medication, including off-label Ozempic.
What Insurance Companies Require
Even if your doctor is willing to prescribe, your insurer may have different ideas. Insurance companies use prior authorization to control access to these medications, and their BMI requirements often mirror the clinical thresholds but come with additional hoops.
UnitedHealthcare, for example, requires a BMI of 30 or above, or a BMI of 27 or above with a documented weight-related condition like high blood pressure, high cholesterol, type 2 diabetes, or sleep apnea. They also require that you’re using the medication alongside lifestyle changes such as dietary modifications, exercise, or a behavioral support program. Some state-specific plans set the bar even higher. Fully insured plans in North Dakota, for instance, require a BMI of 40 or above for coverage.
Insurers also check whether the medication is working at renewal time. For Wegovy specifically, UnitedHealthcare requires you to have lost at least 5% of your starting body weight to continue coverage. If you haven’t hit that mark, they can deny reauthorization.
For Ozempic prescribed specifically for type 2 diabetes, the prior authorization process looks different. Insurers focus on your diabetes diagnosis and whether you’ve tried other blood sugar medications first, not your BMI. This is one reason some doctors prescribe Ozempic rather than Wegovy for patients who have both diabetes and obesity: the diabetes indication can make insurance approval simpler.
Off-Label Prescribing and What to Expect
A significant number of Ozempic prescriptions are written off-label for weight management in people who don’t have type 2 diabetes. This is legal and common, but it creates a gray area. Your doctor decides whether you’re a good candidate based on your overall health, BMI, and risk factors. Most will use the 27/30 BMI framework as their baseline, though some telehealth services and weight loss clinics may be more flexible.
The practical challenge with off-label prescriptions is cost. If your insurer won’t cover Ozempic for weight loss (and many won’t, since it’s not approved for that use), you’ll face the retail price, which can run over $900 per month without discount programs. Wegovy, being FDA-approved for weight management, has a clearer path to insurance coverage for that purpose, though availability and formulary restrictions vary widely.
How Treatment Typically Works
Ozempic is a once-weekly injection you give yourself, usually in the stomach, thigh, or upper arm. You rotate the injection site each week. The starting dose is low and gradually increases over several weeks to reduce side effects, particularly nausea.
Most people begin at 0.25 mg weekly for the first four weeks. This is considered a non-therapeutic dose, meaning it’s not yet strong enough to have a meaningful effect on blood sugar or appetite. It simply lets your body adjust. After four weeks, the dose increases to 0.5 mg. From there, your doctor may raise it further based on how you’re responding, up to a maximum of 2 mg per week.
Nausea, vomiting, diarrhea, and constipation are the most common side effects, especially during dose increases. These typically improve as your body adjusts over a few weeks. Eating smaller meals and avoiding high-fat foods can help during the transition periods.
What Determines Whether You’ll Get a Prescription
In practice, three factors determine whether you walk away with an Ozempic prescription: your diagnosis, your BMI relative to the thresholds above, and your insurance plan’s formulary. If you have type 2 diabetes, BMI is largely irrelevant to eligibility. If you’re seeking it for weight loss, expect your provider to evaluate you against the 27/30 BMI framework and to document any weight-related health conditions that support the prescription. Having a condition like high blood pressure or high cholesterol alongside a BMI of 27 to 29 can make the difference between approval and denial, both from your prescriber and your insurer.